Psylin Neurosciences Commences Development of Compound for DepressionSAN DIEGO - Psylin Neurosciences Inc., a joint venture biotechnology company spun out of Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. announced today that it has initiated IND-enabling development of a novel compound, PSN0041, for the treatment of depression. Amira Initiates Phase I Clinical Trial of Novel DP2 AntagonistSAN DIEGO - Trial Will Evaluate Safety, Proof of Mechanism of a Potential Oral Antagonist for the Treatment of Asthma and COPD Hudson Highland Group Schedules Conference Call and Webcast to Discuss First Quarter Financial ResultsNEW YORK - Hudson Highland Group, Inc. (Nasdaq: HHGP), a leading provider of permanent recruitment, contract professionals and talent management services worldwide, today announced that it will release first quarter financial results for the period ended March 31, 2009 after the market closes on May 4, 2009. Chiquita to Report First Quarter 2009 Financial Results April 30, 2009CINCINNATI - Chiquita Brands International, Inc. (NYSE: CQB) will release first quarter 2009 financial results on April 30, 2009, after the market closes and will host a conference call at 4:30 p.m. EDT that day. Mersana’s Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research MeetingCAMBRIDGE, Massachusetts - Data Show Fleximer(R) Extends Exposure to Conjugated Drug - Mersana, a platform-based cancer therapeutics company, today announced positive results of preclinical studies for its second development candidate, XMT-1107, in two posters at the 2009 Annual Meeting of the American Association of Cancer Research (AACR) in Denver. comScore Reveals Top 15 Online Banking Properties in EuropeLONDON - 1/3 of Total European Internet Audience Visited Online Banking Sites in February - comScore Chairman Gian Fulgoni and SVP Paul Goode to Speak at Valencia Festival of Media Limelight Networks Appoints George Fraser Vice President, EMEA and Asia PacificTEMPE, Arizona - Limelight Networks, Inc. (Nasdaq: LLNW) today announced that the company has appointed Mr. George Fraser, a seasoned executive with over 20 years of experience in the telecommunications and mobile industries, to the position of Vice President, EMEA and Asia Pacific. Cell Biosciences Launches Next-Generation Protein Characterization SystemPALO ALTO, California - Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the launch of the Cell Biosciences CB1000 protein analysis system, a next-generation platform for ultrasensitive characterization of cell signaling proteins. The CB1000 establishes a new standard for sensitivity, reproducibility, and ease-of-use for researchers studying signaling pathways in limited samples, such as small tumor biopsies and stem cells. The CB1000 will be unveiled at the American Association for Cancer Research (AACR) 100th Annual Meeting, April 18-22, 2009, in Denver, Colorado (booth 2039). Saebo United Kingdom Posts Record 2008; Sees Continued Growth in UK for 2009CHARLOTTE, North Carolina - National Health Service hospitals’ usage by stroke rehab patients dictates increase in staff and Saebo-trained therapists Deezer Radio Now Playing All Over the House With SonosHILVERSUM, The Netherlands - 30 European countries now have free access to Deezer Radio on Sonos Facebook Ranks as Top Social Networking Site in the Majority of European CountriesLONDON - Facebook Captures #1 Ranking in Spain for the First Time in February comScore, Inc. (Nasdaq: SCOR), a leader in measuring the digital world, today released an analysis of Facebook’s growth in Europe during the past year. As the popular social networking site has increasingly focused its attention on global expansion and increased penetration across countries and regions, the site has catapulted to the #6 ranked Web property worldwide with 275 million visitors in February, a 175-percent increase versus year ago. One of the global regions that best illustrates Facebook’s growth is Europe, where the site has seen a 314-percent increase to nearly 100 million visitors. Accera, Inc. Launches Neuera Pharmaceuticals, Inc.BROOMFIELD, Colorado - New Business Spin-off to Focus on Drug Development for Neurological Conditions Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.NEW YORK - A top biotech executive, William Pursley, has agreed to become Chairman of Rx for Africa, Inc.’s (Pink Sheets: RXAF) newly created Business Advisory Board. For 25 years Mr. Pursley has held major executive positions in the biotech industry. In 1985 he joined Genentech, Inc., and was on the marketing team that launched Human Growth Hormone (HGH), one of biotech’s first products. It was a huge success. In 1985 Pursley joined Genzyme Corp as VP of Marketing and spearheaded the launch of Ceradase, an Orphan Drug for the treatment of Gaucher’s Disease. Only 3,000 people in the US suffer from Gaucher’s. Hopes were that the drug would reach US$40 million in sales by the third year on the market. It did US$120 million in year three. Ceradase has gone on to be Genzyme’s biggest seller. It’s sales currently exceed US$600 million. Genzyme’s market cap exceeds US$18 billion. Mr. Pursley subsequently became CEO of Osiris Therapeutics, Inc., a leading mesenchymal stem cell company, which recently announced a major corporate alliance with Genzyme. Cell Biosciences Announces Publication in Nature MedicinePALO ALTO, California - Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the publication of a landmark study by a research team from Stanford University School of Medicine. Dr. Dean W. Felsher, Associate Professor of Oncology, was senior author on the study. The publication, titled “Nano-fluidic proteomic assay for serial analysis of oncoprotein activation in clinical samples”, appeared on April 12, 2009 as an Advance Online Publication in the prestigious journal Nature Medicine. In this work, the authors report on new methods for detecting small modifications in cancer-related proteins. Importantly, the exceptional sensitivity of the methods enabled oncoprotein studies in extremely small tumor samples derived from cancer patients. This work was performed using a protein analysis system from Cell Biosciences. ‘Topical Dermatological Product Development in the USA’ Workshop to Be Held on June 4, 2009 in East Brunswick, New Jersey, USAPETALUMA, California - Featuring US experts in topical dermatological drug development Dow Pharmaceutical Sciences, Inc. today announced that it will hold a 1-day workshop on “Topical Dermatological Product Development in the USA” June 4, 2009 at the Hilton East Brunswick, New Jersey. Cell Biosciences Closes US$10 Million Series C FinancingPALO ALTO, California - Cell Biosciences, a provider of nanoproteomic analysis systems to life science researchers, today announced the closing of a US$10 million Series C financing led by its largest shareholder, the Wellcome Trust. Existing investors Domain Associates, Latterell Venture Partners, Novo A/S, Mitsui Ventures, Royal Bank of Canada and The Vertical Group also participated in the financing. Chiquita Appoints Ritchey Chief Accounting OfficerCINCINNATI - Chiquita Brands International (NYSE: CQB) announced today that the company’s board of directors has appointed Lori A. Ritchey, 45, as vice president, controller and chief accounting officer effective April 9, 2009. Ritchey will report to Jeffrey M. Zalla, Chiquita’s senior vice president and chief financial officer. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology BusinessBALTIMORE - Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established a UK subsidiary, Champions Biotechnology UK Ltd. (CBUK), to expand its personalized oncology business. Guy Malchi has been appointed General Manager of the UK subsidiary, which will also have a branch in Israel. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventisPRINCETON, New Jersey - BioWa, Inc. announced today that it has entered into a license agreement with sanofi-aventis (EURONEXT: SAN and NYSE: SNY), providing the global healthcare company with access to BioWa’s POTELLIGENT(R) Technology platform for the research, development and commercialization of their antibody therapies with enhanced antibody-dependent cellular cytotoxicity (ADCC). KMD Partners with Stonebranch for Its Managed File Transfer NeedsATLANTA - Stonebranch provides additional Intelligent File Transfer functionality to leading Danish IT Company Electro-Motive Diesel, Inc. is Awarded New Locomotive Contract for 25 SD70ACS Locomotives from Saudi Railway Company (SAR)RIYADH, Saudi Arabia - Electro-Motive Diesel, Inc. (EMD) today announced it has signed the contract with the Public Investment Fund - Ministry of Finance to manufacture a quantity of 25 SD70ACS heavy haul AC diesel electric locomotives for Saudi Railway Company (SAR). These units are specifically designated for used on the North - South line. They will carry minerals on over 1482km of newly constructed track, and are capable of dealing with some of the harshest desert environments including a 300 km across the Nofud desert. Delivery of the locomotives is scheduled to begin during the 2nd Quarter of 2010. This will bring the number of EMD locomotives operating in Saudi Arabia to 72 locomotives. Michael Manos Joins Digital Realty TrustSAN FRANCISCO - Manos to Serve as Senior Vice President of Technical Services Digital Realty Trust, Inc. (NYSE: DLR), the world’s largest wholesale datacenter provider, announced today that Michael Manos is joining the Company to serve as its Senior Vice President of Technical Services. Manos joins Digital Realty Trust from Microsoft where he was General Manager of Data Center Services and was responsible for datacenter architecture, construction, design, operations and research for all Microsoft datacenters around the world. In his new position at Digital Realty Trust, Manos will oversee datacenter design and construction across the Company’s global portfolio of properties as well as oversee Technical Operations for the organization. Manos will also spearhead the launch of a new professional services offering that the Company will unveil shortly. Fisker Automotive to Receive Additional US$85M for Development of Plug-In Hybrid CarsIRVINE, California - Fisker Automotive, Inc., a leading producer of advanced green technology automobiles, announced today it has entered into definitive agreements to receive an additional US$85 million in venture capital funding for the development and manufacturing of its Karma plug-in hybrid automobiles. The financing is expected to be completed this month and will be the fourth and largest investment round since the company’s inception in August 2007. AboveNet Joins Equinix Financial Exchange and Enhances Connectivity Options Between Equinix’s London Data CentresLONDON - New Service to Provide Direct Access Between Equinix Financial eXchange Community in Slough and Financial Firms in the City Entrust Strengthens Global Leadership Role in ePassport Technology With Support for Master List SigningDALLAS - Entrust to present ePassport capabilities at Nigerian ICAO event Just six months after an impressive showing at the ePassports EAC Conformity & Interoperability Tests in Prague, Czech Republic, Entrust, Inc. (Nasdaq: ENTU) aims to further strengthen its global leadership position. The ePassport security expert will express strong support for the creation of Master List Signing during this week’s ICAO Regional Seminar on Machine Readable Travel Documents (MRTDs), Biometrics and Security Standards in Abuja, Nigeria. Hospira Launches Piperacillin/Tazobactam for Injection in the UKLONDON - Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has received marketing authorisation for piperacillin/tazobactam for injection, and has launched the product in the United Kingdom. The medication is a generic version of Wyeth’s Tazocin(R), the world’s leading injectable antibiotic, with 2008 European sales of approximately 250 million euros.(1) Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure PatientsANN ARBOR, Michigan - Sustained Benefits for Patients Awaiting Transplantation The DuraHeart(TM) Left Ventricular Assist System (LVAS) shows sustained benefits in providing safe and reliable long-term circulatory support with an improved survival rate and an acceptable adverse event rate in advanced heart failure patients who were eligible for transplantation. These conclusions, based on the European experience with DuraHeart, the first active magnetically levitated centrifugal left ventricular assist system, are published on line in the European Journal of Cardio-thoracic Surgery (EJCTS) at dx.doi.org/10.1016/j.ejcts.2008.12.033. Global Therapeutics Manufacturer Selects TrackWise(R) to Reduce the Cost of ComplianceHOLMDEL, New Jersey - Chiesi Farmaceutici Chooses Sparta Systems’ Solution to Ensure Meticulous Audit Control Management Xiocom Wireless Teams With aCure Technology to Deliver Wireless Broadband Campus-Wide Access to 163 Year-Old CollegeATLANTA - Xiocom Wireless announced today that aCure Technology, a value-added reseller and systems integration partner, has deployed a campus-wide indoor and outdoor wireless mesh network solution at Mercedes College in Perth, WA. Students will now be able to work wherever they are on campus, wirelessly accessing all of the college’s resources online. Synopsys and King Abdulaziz City of Science and Technology Promote Nanoelectronics in Saudi ArabiaRIYADH, Saudi Arabia - Collaboration aims to promote knowledge-based society by enabling a Center of Excellence for Nanoelectronic Design First Patients Enrolled in the Access-Europe Study of The MitraClip(R) TherapyMENLO PARK, California - European Post Market Observational Study Intended to Collect Data to Demonstrate the Clinical and Health Economic Benefits of the MitraClip(R) Therapy for Patients with Mitral Regurgitation NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative TechnologySAN JOSE, California - Minimally Invasive Treatment for Varicose Veins to be showcased at National Health Service EXPO Xiocom Wireless Appoints Troy Richardson as Chief Executive OfficerATLANTA - Xiocom Wireless, Inc., a global provider of integrated wireless broadband solutions, announced the appointment of Troy Richardson as Chief Executive Officer today. Troy Richardson succeeds Jeff Spence, who has served in the position since July 2007. Xiocom Wireless Appoints Jeff Spence as the Vice Chairman of the Board of DirectorsATLANTA - Xiocom Wireless, Inc., a global provider of integrated wireless broadband solutions, announced today the appointment of Jeff Spence as its Vice Chairman of the Board of Directors. Mr. Spence has been a Board member since the inception of the company in July 2007. “Due to his experience and commitment to Xiocom for almost two years, he will now take on new accountability for our global investment and capitalization. We welcome his contributions to our future success as we expand into new markets, around the world,” stated Emil Burhmann, Chairman of the Board. Level 3 Announces New Wavelength Service OfferingsBROOMFIELD, Colorado - Enhanced Services Expand High-Speed Bandwidth Options in North America and Europe |
